Adeno-Associated Virus (AAV) CDMO Market to Reach USD 3.90 Billion by 2035 as Gene Therapy Manufacturing Outsourcing Accelerates – SNS Insider
Growing gene therapy pipelines, rare-disease programs, GMP capacity demand, and increasing reliance on specialized CDMOs are expanding AAV manufacturing opportunities.…